INTELLECTUAL PROPERTY
Protection Is Structured Around Technology, Know-How and Defined Rights.
Pharmact’s IP position combines patent rights and applications, proprietary know-how and contractual controls around D016 and relevant development pathways. Public information is separated from confidential technical and transaction-level disclosure.
Protection layer and disclosure level are not the same thing.
PROTECTION ARCHITECTURE
The protection position around D016 is built from multiple legal and technical layers. Each layer has a different function and a different disclosure threshold.
Granted patents and pending applications may protect defined technology, compositions, methods, processes or applications, depending on the claims, jurisdiction and current legal status.
Patent scope is determined by the applicable claims – not by a website description.Protected value may also reside in sequence-related know-how, manufacturing, purification, analytics, formulation, quality documentation and application-specific development knowledge.
Not all commercially relevant know-how is or should be publicly disclosed.Confidentiality, supply, licensing, co-development and transaction agreements define the rights, disclosure scope and permitted use applicable to a specific partner relationship.
Access to material or information does not itself grant IP rights.DISCLOSURE LEVELS
Information is provided at the level appropriate to the purpose, qualification and contractual stage of the discussion.
Public patent publications, high-level technology positioning, public scientific evidence and general partnering information.
Selected technical documentation, current patent schedules, ownership and status information, relevant legal context and project-specific information under an appropriate confidentiality framework.
Detailed chain-of-title, jurisdiction and status review, relevant agreements, claim-level assessment and other information required for a defined licensing, co-development or strategic transaction.
LEGAL DISTINCTIONS
These concepts answer different legal questions and should not be treated as interchangeable.
Defines rights arising from granted patent claims and the potential scope of pending applications in the relevant jurisdiction.
A patent does not by itself provide an unrestricted right to practice a technology.Assesses relevant third-party rights for a defined product, use, jurisdiction and point in time. FTO is context-specific and may require updating as facts or rights change.
FTO is a legal assessment, not a guarantee and not an ownership right.Creates contractual permission to use defined rights within an agreed field, territory, application, development program or commercialization scope.
A license grants only the rights expressly agreed.CURRENT PUBLIC POSITION
Pharmact maintains an international IP and know-how position around D016 and relevant applications. Detailed patent schedules are controlled legal and due-diligence material and are reviewed for current status, ownership, jurisdiction and scope before transaction use.
TECHNICAL DIFFERENTIATION & IP
D016’s designed PH20-like / HYAL4-like dual-activity profile is a key technical differentiating feature of the platform.
The existence and scope of patent protection are determined by the claims and legal status of each relevant patent or application. Technical differentiation alone is not a statement of patent coverage, enforceability or freedom to operate.
VIEW D016 TECHNOLOGY →QUALIFIED IP REVIEW
The depth of legal and technical disclosure depends on the requested rights, jurisdiction, intended use and transaction structure.
The exact sequence and review depth depend on the engagement model and required rights.
U.S. IP & RIGHTS STRUCTURE
Certain U.S. intellectual-property rights and rights positions may be held or used within the Pantarhin structure. Current registry records and the applicable agreements govern ownership, licensing status and scope.
Corporate affiliation does not by itself change ownership, license scope or other intellectual-property rights.
VISIT PANTARHIN.COM →IP & LICENSING
IP discussions are structured according to intended use, jurisdiction, development stage, requested rights and the required level of technical and legal disclosure.